Óscar Fernández Fernández

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Reciprocal Circular Polarization Handedness Conversion Using Chiral Metamaterials

Óscar Fernández Fernández, Álvaro Gómez Gómez, J. Basterrechea · IEEE Antennas and Wireless Propagation Letters · 2017 · 52 citations

Polarization Conversion, Polarization Rotators, Engineering +8

Empirical analysis of a 2 x 2 MIMO channel in outdoor-indoor scenarios for BFWA applications

E. Richard, Óscar Fernández Fernández, Rafael P. Torres · IEEE Antennas and Propagation Magazine · 2006 · 33 citations

Channel Modeling, Mimo System Subchannels, Mimo System +12